NPI: 1780761866 · LAKE HAVASU CITY, AZ 86403 · Rural Acute Care Hospital · NPI assigned 11/01/2006
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 11/01/2006 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 104,042 | $3.70M |
| 2019 | 92,659 | $3.97M |
| 2020 | 70,798 | $3.58M |
| 2021 | 85,106 | $3.76M |
| 2022 | 77,844 | $3.14M |
| 2023 | 68,926 | $2.92M |
| 2024 | 49,603 | $2.13M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 20,363 | 18,039 | $4.70M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5,194 | 4,621 | $3.08M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 14,840 | 13,631 | $2.88M |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 891 | 788 | $2.15M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 10,756 | 8,761 | $1.83M |
| G0378 | Hospital observation service, per hour | 6,852 | 4,015 | $1.44M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 4,492 | 1,729 | $1.04M |
| 70450 | Computed tomography, head or brain; without contrast material | 5,459 | 4,723 | $986K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,864 | 1,722 | $873K |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,368 | 2,101 | $605K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 2,147 | 1,895 | $601K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,389 | 4,161 | $478K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3,231 | 3,195 | $378K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3,769 | 3,541 | $220K |
| 80053 | Comprehensive metabolic panel | 8,926 | 6,460 | $198K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2,483 | 671 | $194K |
| 93971 | 635 | 577 | $132K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 162 | 144 | $109K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 26 | 25 | $95K |
| 71046 | Radiologic examination, chest; 2 views | 4,826 | 4,516 | $90K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 6,446 | 4,918 | $87K |
| 76641 | 578 | 565 | $78K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 13,819 | 11,176 | $56K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 85 | 80 | $56K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 119 | 115 | $46K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 719 | 662 | $43K |
| 72100 | 667 | 620 | $29K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 74 | 74 | $28K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4,443 | 4,051 | $27K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,794 | 3,036 | $23K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 144 | 141 | $22K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 176 | 163 | $21K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 10,982 | 9,324 | $21K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 5,123 | 4,310 | $20K |
| 77080 | 197 | 194 | $20K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 28,124 | 22,185 | $20K |
| 80076 | 20,866 | 17,299 | $19K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 548 | 342 | $19K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 234 | 210 | $19K |
| 96375 | Therapeutic injection; each additional sequential IV push | 9,707 | 7,672 | $17K |
| 73030 | 921 | 807 | $17K | |
| 71045 | Radiologic examination, chest; single view | 10,401 | 8,844 | $17K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 216 | 175 | $17K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 705 | 570 | $17K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 325 | 272 | $16K |
| 96361 | Intravenous infusion, hydration; each additional hour | 8,900 | 7,264 | $16K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,037 | 936 | $15K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 36,989 | 27,442 | $15K |
| 73562 | 622 | 501 | $13K | |
| 72131 | 59 | 52 | $13K | |
| 73110 | 259 | 221 | $12K | |
| 77066 | Tomosynthesis, mammo | 130 | 128 | $11K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2,161 | 2,026 | $10K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 40 | 38 | $9K |
| 71250 | 155 | 144 | $9K | |
| 73130 | 769 | 623 | $9K | |
| 73610 | 649 | 584 | $9K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2,541 | 2,245 | $8K |
| 74022 | 113 | 107 | $8K | |
| 84484 | 8,733 | 6,329 | $8K | |
| 72110 | 78 | 73 | $8K | |
| 84443 | Thyroid stimulating hormone (TSH) | 3,479 | 2,955 | $7K |
| 73630 | 818 | 725 | $7K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 570 | 495 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 6,489 | 5,057 | $6K |
| 82803 | 766 | 619 | $6K | |
| 74018 | 406 | 364 | $6K | |
| 73502 | 505 | 397 | $6K | |
| 82077 | 2,187 | 1,840 | $5K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 174 | 164 | $5K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 158 | 154 | $5K |
| 0450 | Emergency room services | 117 | 105 | $5K |
| 97161 | 312 | 267 | $4K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 56 | 53 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 5,307 | 4,584 | $4K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 272 | 154 | $4K |
| 87040 | 2,665 | 1,955 | $3K | |
| 87186 | 1,758 | 1,509 | $3K | |
| 83690 | 9,973 | 8,284 | $3K | |
| 83735 | 7,418 | 4,995 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 8,533 | 7,469 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,263 | 1,466 | $3K |
| 72170 | 125 | 109 | $3K | |
| 90715 | 871 | 814 | $2K | |
| 85610 | 7,368 | 5,860 | $2K | |
| 83880 | 2,236 | 1,781 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3,230 | 2,802 | $2K |
| 82728 | 692 | 599 | $2K | |
| 0240U | 613 | 553 | $2K | |
| 85730 | 4,731 | 4,025 | $2K | |
| 81003 | 18,208 | 15,435 | $2K | |
| 59025 | Fetal non-stress test | 877 | 643 | $2K |
| 84703 | 4,124 | 3,740 | $2K | |
| 85379 | 1,836 | 1,615 | $2K | |
| 86140 | 2,041 | 1,788 | $2K | |
| 87430 | 2,010 | 1,917 | $2K | |
| 83605 | 3,880 | 3,010 | $2K | |
| 84702 | 852 | 720 | $2K | |
| 76770 | 60 | 54 | $2K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 153 | 44 | $2K |
| 87070 | 1,239 | 1,095 | $2K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 12 | 12 | $1K |
| 74019 | 40 | 37 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 368 | 326 | $1K |
| 80061 | Lipid panel | 2,163 | 1,814 | $1K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14 | 14 | $1K |
| 81025 | 3,572 | 3,254 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 11,652 | 9,256 | $1K |
| 76818 | 16 | 15 | $1K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 624 | 574 | $1K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 675 | 575 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,760 | 1,469 | $1K |
| 85045 | 10,166 | 7,004 | $1K | |
| 87081 | 2,009 | 1,894 | $1K | |
| 86900 | 2,688 | 2,269 | $845.89 | |
| 76830 | Ultrasound, transvaginal | 79 | 76 | $794.35 |
| C1769 | Guide wire | 190 | 144 | $783.53 |
| 0011A | 36 | 32 | $773.06 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,212 | 528 | $765.76 |
| 86850 | 2,333 | 1,986 | $759.78 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 3,434 | 2,480 | $755.41 |
| 80143 | 43 | 40 | $728.88 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 1,553 | 1,431 | $714.39 |
| 84100 | 1,478 | 821 | $677.56 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 16 | 14 | $648.16 |
| 84439 | 1,299 | 1,097 | $627.03 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 7,792 | 6,544 | $624.65 |
| 96376 | 2,072 | 1,325 | $620.44 | |
| 84145 | 2,258 | 1,718 | $616.73 | |
| 87077 | 2,438 | 2,130 | $614.86 | |
| 82247 | 52 | 45 | $593.20 | |
| 82962 | 7,046 | 4,040 | $577.25 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 2,256 | 1,835 | $574.13 |
| 82248 | 1,472 | 1,190 | $551.22 | |
| 86901 | 2,697 | 2,270 | $512.85 | |
| 80179 | 55 | 52 | $512.46 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,045 | 859 | $510.62 |
| 0012A | 22 | 17 | $477.63 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 146 | 141 | $437.94 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 38 | 37 | $421.74 |
| 72040 | 15 | 12 | $409.62 | |
| 97535 | Self-care/home management training, each 15 minutes | 176 | 105 | $391.13 |
| J1170 | Injection, hydromorphone, up to 4 mg | 3,147 | 2,278 | $384.46 |
| 81001 | 2,101 | 1,928 | $370.06 | |
| 85027 | 589 | 426 | $356.91 | |
| 96523 | 15 | 12 | $341.07 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,589 | 2,060 | $336.53 |
| 76801 | 88 | 81 | $334.53 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 8,341 | 7,072 | $300.23 |
| 36415 | Collection of venous blood by venipuncture | 10,887 | 9,222 | $296.78 |
| J2785 | Injection, regadenoson, 0.1 mg | 64 | 53 | $290.75 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 134 | 129 | $278.43 |
| 82140 | 229 | 188 | $270.00 | |
| 73090 | 29 | 24 | $224.16 | |
| 97165 | 40 | 29 | $223.00 | |
| 87807 | 927 | 884 | $220.32 | |
| J1644 | Injection, heparin sodium, per 1000 units | 2,230 | 880 | $197.14 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 1,575 | 1,417 | $182.60 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 8,540 | 4,713 | $161.07 |
| 12001 | 55 | 52 | $158.61 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,070 | 1,071 | $157.78 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 26 | 20 | $156.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 70 | 66 | $152.90 |
| J2060 | Injection, lorazepam, 2 mg | 2,626 | 1,902 | $144.93 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 22 | 13 | $140.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 213 | 195 | $123.15 |
| 82550 | 489 | 404 | $119.69 | |
| 84132 | 225 | 191 | $119.68 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 389 | 261 | $109.05 |
| 84030 | 57 | 55 | $95.84 | |
| 85651 | 593 | 518 | $87.19 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 834 | 647 | $82.29 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,832 | 2,136 | $81.55 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 3,037 | 2,606 | $72.02 |
| 82607 | 60 | 54 | $71.02 | |
| 73080 | 14 | 13 | $69.93 | |
| J1815 | Injection, insulin, per 5 units | 268 | 119 | $67.74 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 109 | 100 | $63.86 |
| 96367 | 701 | 395 | $62.10 | |
| C9113 | Injection, pantoprazole sodium, per vial | 1,103 | 808 | $59.35 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 2,521 | 2,489 | $55.59 |
| J2704 | Injection, propofol, 10 mg | 4,298 | 3,881 | $50.52 |
| 99152 | 494 | 429 | $46.65 | |
| 87205 | 654 | 547 | $44.20 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,459 | 1,243 | $41.35 |
| 36600 | 404 | 322 | $34.12 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 612 | 562 | $31.93 |
| 99153 | Mod sedat endo service >5yrs | 1,322 | 1,154 | $30.26 |
| 87075 | 17 | 12 | $28.62 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,010 | 685 | $27.22 |
| 87210 | 90 | 84 | $26.83 | |
| 99000 | 13 | 13 | $22.77 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 653 | 581 | $17.00 |
| 83540 | 239 | 216 | $16.38 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 626 | 465 | $15.74 |
| 83615 | 37 | 26 | $10.90 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 85 | 29 | $8.10 |
| 82570 | 28 | 24 | $6.51 | |
| A9270 | Non-covered item or service | 1,316 | 805 | $5.26 |
| 84550 | 46 | 37 | $2.91 | |
| J1630 | Injection, haloperidol, up to 5 mg | 50 | 40 | $1.46 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 123 | 74 | $1.26 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 113 | 83 | $0.10 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 89 | 84 | $0.00 |
| J3371 | Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg | 203 | 167 | $0.00 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 221 | 212 | $0.00 |
| 85007 | 66 | 57 | $0.00 | |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 57 | 49 | $0.00 |
| 90670 | 75 | 55 | $0.00 | |
| 90461 | 68 | 61 | $0.00 | |
| 76000 | 65 | 57 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 48 | 44 | $0.00 |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 16 | 12 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 77 | 64 | $0.00 |
| 97116 | 148 | 73 | $0.00 | |
| 73590 | 16 | 12 | $0.00 | |
| 82565 | 17 | 12 | $0.00 | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 18 | 14 | $0.00 |
| 84112 | 13 | 12 | $0.00 | |
| 76937 | 12 | 12 | $0.00 | |
| J3480 | Injection, potassium chloride, per 2 meq | 310 | 171 | $0.00 |
| 88304 | 15 | 15 | $0.00 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 85 | 45 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 161 | 144 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 30 | 25 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 106 | 72 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 353 | 177 | $0.00 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 12 | 12 | $0.00 |
| 83550 | 51 | 49 | $0.00 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 47 | 27 | $0.00 |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 54 | 47 | $0.00 |
| 90698 | 47 | 29 | $0.00 | |
| 94760 | 13 | 13 | $0.00 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 43 | 40 | $0.00 |
| G0238 | Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring) | 20 | 12 | $0.00 |
| 90744 | 29 | 14 | $0.00 | |
| 36416 | 17 | 14 | $0.00 | |
| 90656 | 25 | 17 | $0.00 | |
| 91301 | 15 | 15 | $0.00 | |
| J1940 | Injection, furosemide, up to 20 mg | 15 | 12 | $0.00 |
| 88300 | 12 | 12 | $0.00 | |
| C9399 | Unclassified drugs or biologicals | 46 | 42 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 15 | 13 | $0.00 |
| 88307 | 15 | 13 | $0.00 |